Autopsy report · NCT02989870
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
Cause of deathSlow enrollment
“No Interest. Investigator was unable to enroll any participants on study.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Sponsor type
- University, hospital or other
- Conditions
- HepatoCellular Carcinoma; Unresectable HepatoCellular Carcinoma; Liver Cancer
- Interventions
- Stereotactic Body Radiation Therapy (SBRT); Sorafenib; Bavituximab
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effect of an Intervention Based on Back School in an Aquatic Environment on Non-specific Low Back Pain
“The study was not initiated following an investigator decision not to proceed; no participants were enrolled.” - Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)
“No participants were enrolled, no funding obtained to perform study” - Identification of Elderly Patients in Need of Palliative Care by Family Physicians
“We were not able to recruit participants to enrol the study. As it was not able, the investigation team decided not to proced.” - Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation
“Study was not initiated. No subjects were screened or enrolled.” - Body Composition and Lifestyle Factors in ROTC
“The study did not enroll participants”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.